EXTELLIA THERAPEUTICS
Intellia Therapeutics, Inc.
Published for Opposition: 2016-05-31
Trademark Application Details
FIFTH EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86864974 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Jonathan M. Gelchinsky |
| Attorney Docket Number | 33485/3776D |
| Law Office Assigned | M60 |
| Employee Name | LEIPZIG, MARC J |
Timeline
| 2016-01-04 | Application Filed |
| 2016-05-31 | Published for Opposition |
| 2018-12-31 | Location: INTENT TO USE SECTION |
| 2018-12-31 | Status: Live/Pending |
| 2019-01-01 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Intellia Therapeutics, Inc. |
| Address | Suite 303 25 First Street Cambridge DE 02141 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260129 | DNA helix; Helixes |
| 270305 | Objects forming letters or numerals |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; scientific study and research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services; Design of bioinformatic algorithms and models for use in scientific and medical research in the fields of gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy to develop human pharmaceutical and biological preparations to be delivered or applied ex vivo to human cells for use in human therapeutics and diagnostic products and services |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-01-07 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-01-12 | 2 NWOS I:Incoming Correspondence |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2016-01-13 | 3 MDSC E:E-Mail |
| ASSIGNED TO EXAMINER | 2016-04-19 | 4 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2016-04-19 | 5 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2016-04-19 | 6 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2016-04-19 | 7 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2016-04-19 | 8 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-04-19 | 9 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-05-11 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-05-31 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-05-31 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2016-07-26 | 13 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-01-23 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2017-01-23 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2017-01-23 | 16 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-01-25 | 17 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-07-14 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2017-07-14 | 19 EXT2 S: |
| EXTENSION 2 GRANTED | 2017-07-14 | 20 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-07-18 | 21 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2017-11-16 | 22 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2017-11-16 | 23 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2018-01-02 | 24 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2018-01-02 | 25 EXT3 S: |
| EXTENSION 3 GRANTED | 2018-01-02 | 26 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-01-04 | 27 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2018-06-20 | 28 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2018-06-20 | 29 EXT4 S: |
| EXTENSION 4 GRANTED | 2018-06-20 | 30 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-06-22 | 31 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-10-23 | 32 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-10-23 | 33 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2018-12-14 | 34 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-12-31 | 35 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2018-12-14 | 36 EXT5 S: |
| EXTENSION 5 GRANTED | 2018-12-31 | 37 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-01-01 | 38 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2019-08-26 | 39 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2019-08-26 | 40 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 EXTELLIA THERAPEUTICS 86864974 not registered Live/Pending |
Intellia Therapeutics, Inc. 2016-01-04 |
 EXTELLIA THERAPEUTICS 86864972 not registered Live/Pending |
Intellia Therapeutics, Inc. 2016-01-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 